In a bid to expand into the larger, more lucrative type 2 diabetes market, the medical device maker offers a performance guarantee to payers and employers tied to its MiniMed 670G insulin pump system.

The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device will no longer have to ...

The MiniMed 670G includes a sensor attached to the body to measure glucose levels under the skin and an insulin pump strapped to the body. Attached to the pump is an infusion patch with a catheter ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

All hybrid closed-loop systems improved time in range and time below range compared with other insulin therapies ... alternative HCL systems: MiniMed 670G and MiniMed 780G (Medtronic); t:slim ...